Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

Gilbane, Adrian J, Denton, Christopher P, Holmes, Alan M·2013·Arthritis Research & Therapy

Cited by (197)

Items 101–197 of 197

  1. Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease
    Sydney B. Montesi, Peter D. Caravan · 2019 · Current Rheumatology Reports
  2. Novel role of long non-coding RNAs in autoimmune cutaneous disease
    Anastasiya Muntyanu, Michelle Le, Zainab Ridha, Elizabeth A. O’Brien, Ivan V. Litvinov, Philippe Lefrançois, Elena Netchiporouk · 2021 · Journal of Cell Communication and Signaling
  3. Interstitial lung disease in the connective tissue diseases; a paradigm shift in diagnosis and treatment
    Paul F. Dellaripa · 2017 · Clinical Immunology
  4. α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis
    Yosuke Kanno, En Shu, Hiroyuki Kanoh, Ayaka Matsuda, Mariko Seishima · 2017 · Arthritis Research & Therapy
  5. Inflammatory Memory in Chronic Skin Disease
    Joseph A. Daccache, Shruti Naik · 2024 · JID Innovations
  6. α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
    Yosuke Kanno, En Shu · 2022 · Life
  7. Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B
    Hope A. Flaxman, Maria-Anna Chrysovergi, Hongwei Han, Farah Kabir, Rachael T. Lister, Chia‐Fu Chang, Robert Yvon, Katharine E. Black, Andreas Weigert, Rajkumar Savai et al. · 2024 · JCI Insight
  8. Pathophysiological Mechanisms in Sclerosing Skin Diseases
    Beate Eckes, Fang Wang, Pia Moinzadeh, Nicolas Hunzelmann, Thomas M. Krieg · 2017 · Frontiers in Medicine
  9. Right Ventricle Remodeling and Function in Scleroderma Patients
    Roxana Cucuruzac, Iolanda Muntean, Imre Benedek, András Mester, Nóra Raț, Adriana Mitre, Monica Chițu, Theodora Benedek · 2018 · BioMed Research International
  10. Mitochondrial DNA-Sensing Pathogen Recognition Receptors in Systemic Sclerosis-Associated Interstitial Lung Disease: a Review
    Alexander Ghincea, Samuel Woo, Sheeline Yu, Taylor Pivarnik, Vitória Fiorini, Erica L. Herzog, Changwan Ryu · 2023 · Current Treatment Options in Rheumatology
  11. Insight into the role of dermal white adipose tissue loss in dermal fibrosis
    Si‐Yu Liu, Jun‐Jie Wu, Zhong‐Hua Chen, Ming‐Li Zou, Ying‐Ying Teng, Kai‐Wen Zhang, Yue‐Yue Li, Dang‐Yang Guo, Feng‐Lai Yuan, Xia Li · 2021 · Journal of Cellular Physiology
  12. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts
    Zorica Janjetović, Shariq Qayyum, Sivani B. Reddy, Ewa Podgórska, Steven Gates Scott, Justyna Szpotan, Alisa A. Mobley, Wěi Li, Vijay K. Boda, Ravichandran Senthilkumar et al. · 2024 · Cells
  13. MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice
    Yosuke Kanno, En Shu, Hirofumi Niwa, Mariko Seishima, Kei‐ichi Ozaki · 2021 · Molecular Biology Reports
  14. Role of adipokines in systemic sclerosis pathogenesis
    Klaus Frommer, Elena Neumann, Ulf Müller‐Ladner · 2020 · European Journal of Rheumatology
  15. Association between neutrophil/lymphocyte ratio and disease severity in scleroderma patients
    Fatemeh Nejatifar, Neda Mirbolouk, Irandokht Shenavar Masooleh, Ehsan Kazemnejad, Banafsheh Ghavidel‐Parsa, Amir Mohammad Ghanbari, Habib Zayeni · 2023 · Heliyon
  16. Role of the mTOR pathway in minor salivary gland changes in Sjogren’s syndrome and systemic sclerosis
    Zeki Soypaçacı, Zeynep Zehra Gümüş, Fulya Çakaloğlu, Mustafa Özmen, Dilek Solmaz, Sercan Gücenmez, Önay Gerçik, Servet Akar · 2018 · Arthritis Research & Therapy
  17. Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis
    Mehrnoosh Pashaei, Elham Farhadi, Hoda Kavosi, Elham Madreseh, Samaneh Enayati, Mahdi Mahmoudi, Aliakbar Amirzargar · 2024 · Inflammopharmacology
  18. Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Alice R Cole, Christopher Paul Denton · 2022 · Current Treatment Options in Rheumatology
  19. Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases
    Mattia Bellan, Francesco Murano, Federico Ceruti, Cristina Piccinino, Stelvio Tonello, Rosalba Minisini, Ailia Giubertoni, Daniele Sola, Roberta Pedrazzoli, Veronica Maglione et al. · 2022 · Diagnostics
  20. Functional autoantibodies directed against cell surface receptors in systemic sclerosis
    Otávio Cabral-Marques, Gabriela Riemekasten · 2017 · Journal of Scleroderma and Related Disorders
  21. Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis
    Zixuan Cheng, Jialin Zhang, Wanying Deng, Shaojian Lin, Donghai Li, Ke Zhu, Qing Qi · 2021 · Bioengineered
  22. Th1- and Th17-Related Cytokines in Venous and Arterial Blood of Sclerodermic Patients with and without Digital Ulcers
    Stefania Nicola, Monica Fornero, Enrico Fusaro, Clara Lisa Peroni, Marta Priora, Giovanni Rolla, Caterina B. Bucca, Luisa Brussino · 2019 · BioMed Research International
  23. Skin fibroblasts in health and disease: From extracellular matrix remodeling to immune regulation
    Sahiti Marella, Maksim V. Plikus, Johann Eli Gudjonsson · 2026 · Journal of Investigative Dermatology
  24. Salirasib Inhibits the Expression of Genes Involved in Fibrosis in Fibroblasts of Systemic Sclerosis Patients
    Mina Sadeghi Shaker, Mohsen Rokni, Hoda Kavosi, Samaneh Enayati, Elham Madreseh, Mahdi Mahmoudi, Elham Farhadi, Mohammad Vodjgani · 2024 · Immunity Inflammation and Disease
  25. Dihydromyricetin, the active component of rattan tea alleviates symptoms of systemic sclerosis and atopic dermatitis through modulation of RORγt and IL17A production in T cells
    Debanjan Sarkar, Anik Pramanik, Sourav Majumdar, Dona Das, Maniprabha Mahato, Anup Pramanik, Sankar Bhattacharyya · 2025 · The Journal of Nutritional Biochemistry
  26. Current and future direction in the management of scleroderma
    Sean M. Brady, Lee S. Shapiro, Shaker A. Mousa · 2016 · Archives of Dermatological Research
  27. Case Report: Chemotherapy-Associated Systemic Sclerosis: Is DNA Damage to Blame?
    Amy Du, Robert Gniadecki, Jan Storek, Mohamed Osman · 2022 · Frontiers in Medicine
  28. Fibronectin-EDA accumulates via reduced ubiquitination downstream of Toll-like receptor 9 activation in SSc-ILD fibroblasts
    Ferhan Tuncer, Melissa Bulik, John J. Villandre, Travis Lear, Yanwen Chen, Beyza Tuncer, Daniel J. Kass, Eleanor Valenzi, Christina Morse, John Sembrat et al. · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  29. Scleroderma (systemic sclerosis)
    Edward Carwile LeRoy · 2001 · CRC Press eBooks
  30. The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities
    Filomena Napolitano, Francesca Wanda Rossi, Amato de Paulis, Antonio Lavecchia, Nunzia Montuori · 2024 · International Journal of Molecular Sciences
  31. Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
    Daria Apostolo, Davide D’Onghia, Alessandra Nerviani, Giulia Maria Ghirardi, Daniele Sola, Mattia Perazzi, Stelvio Tonello, Donato Colangelo, Pier Paolo Sainaghi, Mattia Bellan · 2024 · Current Issues in Molecular Biology
  32. Ayurvedic management of systemic sclerosis - A case report
    Jagruti R. Parmar, Naiya Upadhyay, Mansi Patel, Shivenarain N Gupta · 2024 · Journal of Ayurveda and Integrative Medicine
  33. Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies
    Amanda Saracino, Daniel Kelberman, Georg Otto, Andrey N. Gagunashvili, David Abraham, Christopher Paul Denton · 2023 · Archives of Dermatological Research
  34. Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis
    Sergio A. Jiménez, Sonsoles Piera-Velázquez · 2022 · Rheumatology
  35. TGFβ ‐mediated inhibition of hypodermal adipocyte progenitor differentiation promotes wound‐induced skin fibrosis
    Meimei Yin, Lixiang Sun, Shuai Wu, Jinhang Ma, Wenlu Zhang, Xiaoxuan Ji, Zhichong Tang, Xiaowei Zhang, Yichun Yang, Xinyuan Zhang et al. · 2024 · Cell Proliferation
  36. Systemic Sclerosis and Pulmonary Disease
    Khoa Ngo · 2021 · Advances in experimental medicine and biology
  37. Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma
    Jing Luo, Mingwei Li, Di Zhao, Hong Chen, Junkai Huang, Mengke Sun, Qianyu Zhu, Qi Guo, Sicheng Song, Qianshu Yuan et al. · 2026 · International Immunopharmacology
  38. The cGAS-STING pathway in fibroblast microenvironment: from molecular mechanisms to targeted therapies
    Zhe Zhang, Huidan Deng, Xiyuan Zhang, Jiayan Li, Jianyi Zhao, Junyang Liu, Chao Deng, Yan Yang, Zhenxing Liang · 2026 · APOPTOSIS
  39. Raynaud’s phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report
    Fabio Andrés Torres-Saavedra, Lina Paola León-Sierra · 2022 · BMC Rheumatology
  40. Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients
    Simona Zanotti, Marina Mora · 2017 · Methods in molecular biology
  41. Digital ulcers associated with scleroderma: A major unmet medical need
    Angha Naik, Richard J. Stratton, Andrew Leask · 2024 · Wound Repair and Regeneration
  42. High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma
    Katariina Mähönen, Isabel Mogollón, Antti Hassinen, Minttu Polso, Katja E. Välimäki, Swapnil Potdar, Al-Amin Chowdhury, Annamari Ranki, Jani Saarela, Vilja M. Pietiäinen et al. · 2025 · Acta Dermato Venereologica
  43. Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases
    Xintao Tu, Thao-Nguyen Bach, Arjun S. Baghela, Mark Zielstorff, William Smallridge, Qian Chen, Soha Motlagh, Travis Barr, Marc Alexander Sze, In Sock Jang et al. · 2026 · Rheumatology
  44. Lung involvement in systemic sclerosis
    Corrado Campochiaro, Cosimo Bruni, Sara Tomassetti, Lorenzo Dagna, Marco Matucci‐Cerinic · 2022 · Technical report
  45. Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis
    Kimberly Showalter Lakin, John Spivack, Jessica Gordon, Yaxia Zhang, Deanna Jannat‐Khah, Hiranmayi Ravichandran, Niroshana Anandasabapathy, Dana E. Orange, Robert Spiera · 2025 · Arthritis & Rheumatology
  46. A Review of the Therapeutic Potentials of Stem Cells, Fibroblast Growth Factors and T-cells in Regenerative Medicine
    Adedeji Okikiade, Aromedonghene Osharode, Olayinka Afolayan-Oloye, Damisola Ogunesan, Adijat Oyewole, K. Uba Chibuike, Kevin D. Browne · 2022 · Advances in Research
  47. T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models
    Isha Singh, Madeline J Morrisson, Sasha Shenk, Helen C. Jarnagin, Johanna Hauer, Ayesha Lobo, Lori Brown, Tamara Houck, Liora Altman-Sagan, Patricia Ann Pioli et al. · 2025 · Tissue Engineering Part C Methods
  48. Fibrosis and Immune Dysregulation in Systemic Sclerosis
    Yahya Argobi, Gideon Piers Smith · 2018 · Molecular and translational medicine
  49. Paraneoplastic Scleroderma: A Case Report of Systemic Sclerosis in the Setting of Pulmonary Adenocarcinoma
    Christopher Marsalisi, Avni Agrawal, Abhinav Karan, Zachary D. Chandler, Pramod Reddy · 2023 · Cureus
  50. Chromosome Segregation Defects in Scleroderma
    Rafael Contreras-Galindo, Souren Paul, Preston M. McCourt · 2023 · IntechOpen eBooks
  51. Systemic Sclerosis in Childhood
    Christopher Paul Denton, Carol M. Black · 2011 · Wiley eBooks
  52. Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Ting Cheng, Heyi Zhang, Tian-Run Wang, Ruolan Li, Zhi-Nan Jing, Yue-Hong Huo, Sheng‐Xiao Zhang · 2025 · Scientific Reports
  53. Clinical utility of echocardiography and magnetic resonance imaging for detecting cardiac complications in Systemic Sclerosis. A case report.
    Bianca Olivia Cojan-Minzat, Carmen Cionca, Isabella Mihalcea, Silvia Lupu, Lucia Agoşton-Coldea · 2015 · Medical Ultrasonography
  54. Hyperbaric Oxygen Therapy for Scleroderma Wounds: A Report on Two Cases and Literature Review
    Chih Yu Fang, Klemen Kerin, Jay C. Buckey · 2025 · Annals of Internal Medicine Clinical Cases
  55. Therapeutic Potential of Tulisokibart and Anti-TL1A Therapy in Inflammatory Disorders: Current Insights and Future Directions
    Juling Sia, Bernett Lee, Hazel Hwee Boon Oon · 2026 · Clinical Reviews in Allergy & Immunology
  56. Cutaneous Fibrosis and Normal Wound Healing
    Emily Hamburg‐Shields, Peggy S. Myung, Shawn E. Cowper · 2017 · Springer eBooks
  57. The place of laser fluorescence spectroscopy, doppler flowmetry and ultrasound in the diagnosis and assessment of treatment efficacy for plaque scleroderma
    Evgeniy F. Khynku, Irina A. Raznitsyna, Yu. V. Molochkova, Д. А. Рогаткин, Elena V. Selesneva, Alexey A. Glazkov, Anton Vladimirovich Molochkov · 2022 · Russian Journal of Skin and Venereal Diseases
  58. Pneumotoxicity of Styrene Oxide and the Possible Protective Role of Thymosin β4 in Albino Rat: Biochemical and Immunohistochemical Study
    Ola Abdelwahab, Eman Reda Abozaid, Reham H. Abdel-Kareem · 2023 · Zagazig University Medical Journal
  59. Physiopathological Mechanisms Involved in the Progression of Pulmonary Fibrosis: A Systematic Review.
    Sana Bahri, Saloua Ben Khamsa Jameleddine · 2022 · PubMed Central
  60. Novel indications for autologous fat grafting in reconstruction: scleroderma
    Abed Rahman Kawakibi, Alexander N. Khouri, Paul Stephen Cederna, Amy L. Strong · 2023 · Plastic and Aesthetic Research
  61. Assessment of the Expression Levels of USP27X and DDX3X genes in Systemic Lupus Erythematosus (SLE) Patients
    Somayeh Ghotloo, Batool Zamani, Amir-Reza Osatadian, Zeynab Marzhoseyni · 2024 · Indian Journal of Rheumatology
  62. Resolution to Inflammation: Its Role in Reducing Fibrosis and Tissue Repair
    Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
  63. Current and future approaches to the treatment of immunologic diseases: new targets and new therapeutic agents
    David A. Fox · 2014 · Translational research
  64. Análise ultraestrutural e implicação do RNA de interferência na fibrilogênese do colágeno V em pacientes com esclerodermia
    Jymenez de Morais · 2014
  65. The role of fibroblast PPAR??/?? in skin homeostasis
    Ming Keat Sng · 2016
  66. The WNT signalling pathway in systemic sclerosis
    Jacqueline Frost · 2016
  67. Treatment of Diffuse Cutaneous Systemic Sclerosis with Hyperimmune Caprine Serum
    Niamh Quillinan · 2016 · UCL Discovery (University College London)
  68. Novel approaches to identify biomechanisms in systemic sclerosis
    Henry Lopez · 2017 · UCL Discovery (University College London)
  69. The role of peroxisome proliferator-activated receptor β/δ in colorectal cancer
    Eddie Han Pin Tan · 2018
  70. The Pathogenesis of Intraabdominal Adhesions: Similarities and Differences to Luminal Fibrosis
    Edward J. Macarak, Joel Rosenbloom · 2018 · Springer eBooks
  71. The Effect of Function-blocking RHAMM Peptides in a Mouse Model of Bleomycin-induced Systemic Sclerosis
    Kitty Yuechuan Wu · 2018 · Scholarship@Western (Western University)
  72. Clinical and diagnostic characteristics of peripheral vasculopathy biomarkers in systemic scleroderma
    Ye.D. Yehudіna, I.Yu. Golovach · 2019 · UMJ Heart & Vessels
  73. Pulmonary involvement in systemic sclerosis
    Athol Umfrey Wells · 2019 · European Respiratory Society eBooks
  74. Pembrolizumab induced scleroderma
    Reem Alkilany, Stanley P. Ballou · 2020 · Discussion of Clinical Cases
  75. Expressão de marcadores de fibrose em pacientes com esclerose sistêmica submetidos a transplante autólogo de células-tronco hematopoéticas
    Djúlio César Zanin da Silva · 2020
  76. Systemic Sclerosis in Childhood
    Christopher Paul Denton, Carol M. Black · 2019 · Wiley eBooks
  77. Conservative treatment of hemifacial atrophy with volume replacement of hyaluronic acid
    Kata Czirbesz, Fanni Baranyai, Ugur Cakir, Ákos Haller, Katinka Pónyai · 2022 · Bőrgyógyászati és Venerológiai Szemle
  78. Systemic Sclerosis - Recent Advances and New Perspectives
    Katja Lakota, Katja Perdan Pirkmajer, Blaž Burja · 2023 · IntechOpen eBooks
  79. Benefícios de um programa domiciliar de cuidados para as mãos na esclerose sistêmica
    Síbila Floriano Landim · 2021
  80. Associations of Digital Ulcers in Patients with Systemic Sclerosis: An 8-Year Retrospective Study
    Miaomiao Chi, Qi An, Xiuyuan Feng, Lan He, Ying‐Xian Pan · 2024 · Dermatology
  81. Additional file 4 of BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
    Jiahui Jin, Qingjian Ou, Zhe Wang, Haibin Tian, Jingying Xu, Furong Gao, Shuqin Hu, Chen, Jie, Juan Wang, Jieping Zhang et al. · 2021 · Figshare
  82. Systemic sclerosis and scleroderma renal crisis in African American patients
    Riti Kotamarti, Kevin V. Hackshaw · 2025 · Journal of the National Medical Association
  83. Possibilities of applying laser-induced fluorescence spectroscopy and Doppler flowmetry methods in the case of plaque morphea
    Evgeniy F. Khynku, Irina A. Raznitsyna, Yu.V. Molochkova, Д. А. Рогаткин, Alexey A. Glazkov, Anton Vladimirovich Molochkov, Мarina А. Gureeva · 2025 · Russian Journal of Clinical Dermatology and Venereology
  84. Additional file 2 of BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
    Jin, Jiahui, Qingjian Ou, Zhe Wang, Haibin Tian, Xu, Jing-Ying, Furong Gao, Hu, Shuqin, Chen, Jie, Wang, Juan, Zhang, Jieping et al. · 2021 · Figshare
  85. Additional file 3 of BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
    Jin, Jiahui, Qingjian Ou, Zhe Wang, Haibin Tian, Xu, Jing-Ying, Furong Gao, Hu, Shuqin, Chen, Jie, Juan Wang, Zhang, Jieping et al. · 2021 · Figshare
  86. Additional file 1 of Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
    Maurizio Cutolo, Emanuele Gotelli, Paola Montagna, Samuele Tardito, Paolino, Sabrina, Carmen Pizzorni, Sulli, Alberto, Smith, Vanessa, Stefano Soldano · 2021 · Figshare
  87. Additional file 1 of BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
    Jin, Jiahui, Qingjian Ou, Zhe Wang, Haibin Tian, Xu, Jing-Ying, Furong Gao, Hu, Shuqin, Chen, Jie, Wang, Juan, Zhang, Jieping et al. · 2021 · Figshare
  88. Towards effective targeted therapies in morphea
    Amanda Saracino, Laxmi Iyengar, Mandana NIKPOUR · 2026 · Italian Journal of Dermatology and Venereology
  89. Therapeutic Approaches to Treat Hypertrophic Scars
    Vanessa C. Smith, Steve Smith, Tugba Ozdemir · 2026 · Stem cell biology and regenerative medicine
  90. Extraction et évaluation des propriétés biologiques des ulvanes et oligo-ulvanes de l'algue verte Ulva sp. : actions sur le métabolisme de cellules cutanées et sur le microbiote cutané
    Mathilde Fournière · 2021
  91. Immunoglobulines G de patients sclérodermiques : optimisation des méthodes de purification, étude de la glycosylation et analyse de l'impact sur le profil protéomique de fibroblastes
    Louisa Bourel · 2024
  92. Beyond Dosage Compensation: Xist and Tsix Orchestrate Fibrosis Through TGF-β Signalling in Systemic Sclerosis
    Dipanjan Bhattacharjee, Sanchaita Misra, Sudipta Chatterjee, Pradyot Sinhamahapatra, Madhurima Basak, Suchandrima Ghosh, Ayindrila Saha, Sulagna Chatterjee, Avik Sarkar, Abhishek Saha et al. · 2026 · Research Square
  93. Juvenile Systemic Sclerosis
    Kathryn S. Torok, Ivan Foeldvari · 2026 · Elsevier eBooks
  94. Loss of CD109 Amplifies NF-κB Signaling and Inflammatory Reprogramming in Dermal Fibroblasts
    Adel Batal, Saniya Pamnani, Shufeng Zhou, George Bou–Gharios, Anie Philip · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Long Non-Coding RNA XIST and TSIX Modulate TGF-β-Mediated Cellular Transdifferentiation and Fibrosis in Systemic Sclerosis
    Dipanjan Bhattacharjee, Sanchaita Misra, Sudipta Chatterjee, Pradyot Sinhamahapatra, Madhurima Basak, Suchandrima Ghosh, Ayindrila Saha, Sulagna Chatterjee, Avik Sarkar, Abhishek Saha et al. · 2026 · Research Square
  96. Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study
    Zachary Warren, Diane Apostolopoulos, Gene‐Siew Ngian, Amanda Saracino, Laura Ross, Nava Ferdowsi, Jennifer G. Walker, Cindy Hall, Kim Griggs, Susanna Proudman et al. · 2026 · Arthritis Care & Research
  97. Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives
    Rasha-Ioana Rămoiu-Shehada, Anca Emanuela Mușetescu, Lucian-Mihai Florescu, Alesandra Florescu, Paulina Lucia Ciurea · 2026 · Life